Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Original investigation

Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia

Authors: Peter Bramlage, Anselm K Gitt, Christiane Binz, Michael Krekler, Evelin Deeg, Diethelm Tschöpe

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Background

We aimed at identifying variables predicting hypoglycemia in elderly type 2 diabetic patients and the relation to HbA1c values achieved.

Design

Prospective, observational registry in 3810 patients in primary care. Comparison of patients in different age tertiles: with an age < 60 (young, n=1,253), age 60 to < 70 (middle aged, n=1,184) to those ≥ 70 years (elderly, n=1,373). Odds Ratios (OR) with 95% confidence intervals (CI) were determined from univariable and multivariable regression analyses.

Results

Elderly patients had a later diabetes diagnosis, a longer diabetes duration, better glucose control and more frequent co-morbid disease conditions. Overall 10.7% of patients experienced any severity hypoglycemia within the last 12 months prior to inclusion. Higher rates of hypoglycemia were observed in the elderly than in the young after adjusting for differences in HbA1c, fasting and post-prandial blood glucose (OR 1.68; 95%CI 1.16-2.45). This was particularly true for hypoglycemic episodes without specific symptoms (OR 1.74; 95%CI 1.05-2.89). In a multivariate model stroke / transitory ischemic attack, the presence of heart failure, clinically relevant depression, sulfonylurea use and blood glucose self-measurement were associated with hypoglycemic events.

Conclusion

Elderly patients are at an increased risk of hypoglycemia even at comparable glycemic control. Therefore identified variables associated with hypoglycemia in the elderly such as heart failure, clinically relevant depression, the use of sulfonylurea help to optimize the balance between glucose control and low levels of hypoglycemia. Asymptomatic hypoglycemia should not be disregarded as irrelevant but considered as a sign of possible hypoglycemia associated autonomic failure.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bremer JP, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B: Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009, 32 (8): 1513-1517. 10.2337/dc09-0114.PubMedCentralCrossRefPubMed Bremer JP, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B: Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009, 32 (8): 1513-1517. 10.2337/dc09-0114.PubMedCentralCrossRefPubMed
2.
go back to reference Zeyfang A, Feucht I, Rukgauer M, Nikolaus T: Anti-aging with healthy nutrition. This you can recommend!. MMW Fortschr Med. 2002, 144 (39): 27-30.PubMed Zeyfang A, Feucht I, Rukgauer M, Nikolaus T: Anti-aging with healthy nutrition. This you can recommend!. MMW Fortschr Med. 2002, 144 (39): 27-30.PubMed
3.
go back to reference Holstein A, Hammer C, Hahn M, Kulamadayil NS, Kovacs P: Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert Opin Drug Saf. 2010, 9 (5): 675-681. 10.1517/14740338.2010.492777.CrossRefPubMed Holstein A, Hammer C, Hahn M, Kulamadayil NS, Kovacs P: Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert Opin Drug Saf. 2010, 9 (5): 675-681. 10.1517/14740338.2010.492777.CrossRefPubMed
4.
go back to reference Lammert M, Hammer M, Frier BM: Management of severe hypoglycaemia: cultural similarities, differences and resource consumption in three European countries. J Med Econ. 2009, 12 (4): 269-280. 10.3111/13696990903310501.CrossRefPubMed Lammert M, Hammer M, Frier BM: Management of severe hypoglycaemia: cultural similarities, differences and resource consumption in three European countries. J Med Econ. 2009, 12 (4): 269-280. 10.3111/13696990903310501.CrossRefPubMed
5.
go back to reference Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B: European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007, 14 (Suppl 2): S1-S113.CrossRefPubMed Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B: European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007, 14 (Suppl 2): S1-S113.CrossRefPubMed
6.
go back to reference Matthaei S, Bierwirth R, Fritsche A, Gallwitz B, Haring HU, Joost HG, Kellerer M, Kloos C, Kunt T, Nauck M: Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association. Exp Clin Endocrinol Diabetes. 2009, 117 (9): 522-557. 10.1055/s-0029-1239559.CrossRefPubMed Matthaei S, Bierwirth R, Fritsche A, Gallwitz B, Haring HU, Joost HG, Kellerer M, Kloos C, Kunt T, Nauck M: Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association. Exp Clin Endocrinol Diabetes. 2009, 117 (9): 522-557. 10.1055/s-0029-1239559.CrossRefPubMed
7.
go back to reference Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P: Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009, 15 (6): 540-559.CrossRefPubMed Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P: Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009, 15 (6): 540-559.CrossRefPubMed
8.
go back to reference Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K: Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007, 28 (1): 88-136.PubMed Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K: Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007, 28 (1): 88-136.PubMed
9.
go back to reference Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009, 32 (1): 193-203. 10.2337/dc08-9025.PubMedCentralCrossRefPubMed Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009, 32 (1): 193-203. 10.2337/dc08-9025.PubMedCentralCrossRefPubMed
10.
go back to reference Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P: Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009, 32 (1): 187-192. 10.2337/dc08-9026.PubMedCentralCrossRefPubMed Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P: Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009, 32 (1): 187-192. 10.2337/dc08-9026.PubMedCentralCrossRefPubMed
11.
go back to reference Brown AF, Mangione CM, Saliba D, Sarkisian CA: Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003, 51 (5 Suppl Guidelines): S265-S280.PubMed Brown AF, Mangione CM, Saliba D, Sarkisian CA: Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003, 51 (5 Suppl Guidelines): S265-S280.PubMed
12.
go back to reference Bramlage P, Binz C, Gitt AK, Krekler M, Plate T, Deeg E, Tschope D: Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline. Cardiovasc Diabetol. 2010, 9: 53-10.1186/1475-2840-9-53.PubMedCentralCrossRefPubMed Bramlage P, Binz C, Gitt AK, Krekler M, Plate T, Deeg E, Tschope D: Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline. Cardiovasc Diabetol. 2010, 9: 53-10.1186/1475-2840-9-53.PubMedCentralCrossRefPubMed
13.
go back to reference Gitt AK, Bramlage P, Binz C, Krekler M, Plate T, Deeg E, Tschöpe D: Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry. Eur J Prev Cardiol. 2012, 19 (4): 765-772. 10.1177/1741826711411104.CrossRefPubMed Gitt AK, Bramlage P, Binz C, Krekler M, Plate T, Deeg E, Tschöpe D: Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry. Eur J Prev Cardiol. 2012, 19 (4): 765-772. 10.1177/1741826711411104.CrossRefPubMed
14.
go back to reference Tschope D, Bramlage P, Binz C, Krekler M, Plate T, Deeg E, Gitt AK: Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients–an analysis of the DiaRegis registry. Cardiovasc Diabetol. 2011, 10: 66-10.1186/1475-2840-10-66.PubMedCentralCrossRefPubMed Tschope D, Bramlage P, Binz C, Krekler M, Plate T, Deeg E, Gitt AK: Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients–an analysis of the DiaRegis registry. Cardiovasc Diabetol. 2011, 10: 66-10.1186/1475-2840-10-66.PubMedCentralCrossRefPubMed
15.
go back to reference Gitt AK, Bramlage P, Binz C, Krekler M, Deeg E, Tschope D: [Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany: Results of the DiaRegis registry]. Herz. 2012, 37 (3): 294-300. 10.1007/s00059-012-3611-3.CrossRefPubMed Gitt AK, Bramlage P, Binz C, Krekler M, Deeg E, Tschope D: [Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany: Results of the DiaRegis registry]. Herz. 2012, 37 (3): 294-300. 10.1007/s00059-012-3611-3.CrossRefPubMed
16.
go back to reference Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care. 2003, 26 (6): 1902-1912. 10.2337/diacare.26.6.1902.CrossRefPubMed Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care. 2003, 26 (6): 1902-1912. 10.2337/diacare.26.6.1902.CrossRefPubMed
17.
go back to reference Chelliah A, Burge MR: Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention. Drugs Aging. 2004, 21 (8): 511-530. 10.2165/00002512-200421080-00003.CrossRefPubMed Chelliah A, Burge MR: Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention. Drugs Aging. 2004, 21 (8): 511-530. 10.2165/00002512-200421080-00003.CrossRefPubMed
18.
go back to reference Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM: Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med. 2001, 161 (13): 1653-1659. 10.1001/archinte.161.13.1653.CrossRefPubMed Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM: Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med. 2001, 161 (13): 1653-1659. 10.1001/archinte.161.13.1653.CrossRefPubMed
19.
go back to reference Segel SA, Paramore DS, Cryer PE: Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes. 2002, 51 (3): 724-733. 10.2337/diabetes.51.3.724.CrossRefPubMed Segel SA, Paramore DS, Cryer PE: Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes. 2002, 51 (3): 724-733. 10.2337/diabetes.51.3.724.CrossRefPubMed
20.
go back to reference Choudhary P, Amiel SA: Hypoglycaemia: current management and controversies. Postgrad Med J. 2011, 87 (1026): 298-306. 10.1136/pgmj.2008.068197.CrossRefPubMed Choudhary P, Amiel SA: Hypoglycaemia: current management and controversies. Postgrad Med J. 2011, 87 (1026): 298-306. 10.1136/pgmj.2008.068197.CrossRefPubMed
21.
go back to reference Amiel SA, Maran A, Powrie JK, Umpleby AM, Macdonald IA: Gender differences in counterregulation to hypoglycaemia. Diabetologia. 1993, 36 (5): 460-464. 10.1007/BF00402284.CrossRefPubMed Amiel SA, Maran A, Powrie JK, Umpleby AM, Macdonald IA: Gender differences in counterregulation to hypoglycaemia. Diabetologia. 1993, 36 (5): 460-464. 10.1007/BF00402284.CrossRefPubMed
22.
go back to reference Davis SN, Shavers C, Costa F: Gender-related differences in counterregulatory responses to antecedent hypoglycemia in normal humans. J Clin Endocrinol Metab. 2000, 85 (6): 2148-2157. 10.1210/jc.85.6.2148.PubMed Davis SN, Shavers C, Costa F: Gender-related differences in counterregulatory responses to antecedent hypoglycemia in normal humans. J Clin Endocrinol Metab. 2000, 85 (6): 2148-2157. 10.1210/jc.85.6.2148.PubMed
23.
go back to reference Jones TW, Porter P, Sherwin RS, Davis EA, O’Leary P, Frazer F, Byrne G, Stick S, Tamborlane WV: Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med. 1998, 338 (23): 1657-1662. 10.1056/NEJM199806043382303.CrossRefPubMed Jones TW, Porter P, Sherwin RS, Davis EA, O’Leary P, Frazer F, Byrne G, Stick S, Tamborlane WV: Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med. 1998, 338 (23): 1657-1662. 10.1056/NEJM199806043382303.CrossRefPubMed
24.
go back to reference Meneilly GS, Cheung E, Tuokko H: Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes. 1994, 43 (3): 403-410. 10.2337/diabetes.43.3.403.CrossRefPubMed Meneilly GS, Cheung E, Tuokko H: Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes. 1994, 43 (3): 403-410. 10.2337/diabetes.43.3.403.CrossRefPubMed
25.
go back to reference Henderson JN, Allen KV, Deary IJ, Frier BM: Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med. 2003, 20 (12): 1016-1021. 10.1046/j.1464-5491.2003.01072.x.CrossRefPubMed Henderson JN, Allen KV, Deary IJ, Frier BM: Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med. 2003, 20 (12): 1016-1021. 10.1046/j.1464-5491.2003.01072.x.CrossRefPubMed
26.
go back to reference Jaap AJ, Jones GC, McCrimmon RJ, Deary IJ, Frier BM: Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin. Diabet Med. 1998, 15 (5): 398-401. 10.1002/(SICI)1096-9136(199805)15:5<398::AID-DIA595>3.0.CO;2-B.CrossRefPubMed Jaap AJ, Jones GC, McCrimmon RJ, Deary IJ, Frier BM: Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin. Diabet Med. 1998, 15 (5): 398-401. 10.1002/(SICI)1096-9136(199805)15:5<398::AID-DIA595>3.0.CO;2-B.CrossRefPubMed
27.
go back to reference Lam SK, Owen A: Incident diabetes in clinical trials of antihypertensive drugs. Lancet. 2007, 369 (9572): 1513-1514. author reply 1514–1515CrossRefPubMed Lam SK, Owen A: Incident diabetes in clinical trials of antihypertensive drugs. Lancet. 2007, 369 (9572): 1513-1514. author reply 1514–1515CrossRefPubMed
28.
go back to reference Elliott WJ, Meyer PM: Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007, 369 (9557): 201-207. 10.1016/S0140-6736(07)60108-1.CrossRefPubMed Elliott WJ, Meyer PM: Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007, 369 (9557): 201-207. 10.1016/S0140-6736(07)60108-1.CrossRefPubMed
29.
go back to reference van Dijk M, Donga E, van Dijk JG, Lammers GJ, van Kralingen KW, Dekkers OM, Corssmit EP, Romijn JA: Disturbed subjective sleep characteristics in adult patients with long-standing type 1 diabetes mellitus. Diabetologia. 2011. van Dijk M, Donga E, van Dijk JG, Lammers GJ, van Kralingen KW, Dekkers OM, Corssmit EP, Romijn JA: Disturbed subjective sleep characteristics in adult patients with long-standing type 1 diabetes mellitus. Diabetologia. 2011.
30.
go back to reference Williams SA, Pollack MF, Dibonaventura M: Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011, 91 (3): 363-370. 10.1016/j.diabres.2010.12.027.CrossRefPubMed Williams SA, Pollack MF, Dibonaventura M: Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011, 91 (3): 363-370. 10.1016/j.diabres.2010.12.027.CrossRefPubMed
31.
go back to reference Hader C, Beischer W, Braun A, Dreyer M, Friedl A, Fusgen I, Gastes U, Grunklee D, Hauner H, Kobberling J: Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter. Diabetes und Stoffwechsel. 2004, 13: 31-56. Hader C, Beischer W, Braun A, Dreyer M, Friedl A, Fusgen I, Gastes U, Grunklee D, Hauner H, Kobberling J: Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter. Diabetes und Stoffwechsel. 2004, 13: 31-56.
32.
go back to reference Hader C, Graf-Gruss R: Diabetes im Alter. DDG Praxis Leitlinie. Diabetologia. 2007, 2: 202-206. 10.1055/s-2007-960642.CrossRef Hader C, Graf-Gruss R: Diabetes im Alter. DDG Praxis Leitlinie. Diabetologia. 2007, 2: 202-206. 10.1055/s-2007-960642.CrossRef
33.
go back to reference Zeyfang A, Bahrmann A, Wernecke J: Diabetes mellitus im Alter. Diabetologie. 2010, 5: 166-171. 10.1055/s-0030-1262596.CrossRef Zeyfang A, Bahrmann A, Wernecke J: Diabetes mellitus im Alter. Diabetologie. 2010, 5: 166-171. 10.1055/s-0030-1262596.CrossRef
34.
go back to reference Sinclair A, Morley JE, Rodriguez-Manas L, Paolisso G, Bayer T, Zeyfang A, Bourdel-Marchasson I, Vischer U, Woo J, Chapman I: Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc. 2012, 13 (6): 497-502. 10.1016/j.jamda.2012.04.012.CrossRefPubMed Sinclair A, Morley JE, Rodriguez-Manas L, Paolisso G, Bayer T, Zeyfang A, Bourdel-Marchasson I, Vischer U, Woo J, Chapman I: Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc. 2012, 13 (6): 497-502. 10.1016/j.jamda.2012.04.012.CrossRefPubMed
Metadata
Title
Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia
Authors
Peter Bramlage
Anselm K Gitt
Christiane Binz
Michael Krekler
Evelin Deeg
Diethelm Tschöpe
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-122

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.